国际标准期刊号: 2161-038X
Judson Brandeis
Background: Male Urinary Incontinence (UI) and Erectile Dysfunction (ED) significantly impact men's well-being, with UI prevalence experiencing a marked increase in recent years. While traditionally studied in women, UI's prevalence among men, particularly those over 60, has notably risen. UI types, such as urgency, mixed, and stress incontinence, often coincide with ED affecting the quality of life and overall sexual health.
Objective: This study aims to assess the safety and efficacy of the HIFEM procedure in improving male urinary function and erectile dysfunction. HIFEM, a novel non-invasive approach, targets pelvic floor muscles, focusing on intensifying and enhancing muscular contractions beyond traditional exercise modalities.
Methods: This pilot study involved 28 men, aged between 27 and 72 years, who were experiencing Urinary Symptoms (UI) and Erectile Dysfunction (ED). They participated in a structured treatment program that included ten weekly HIFEM therapy sessions. The severity of UI was measured using the International Prostate Symptom Score (IPSS), and the severity of ED was evaluated using the International Index of Erectile Function (IIEF). Additionally, penile ultrasound scans were performed both before and after the last treatment to assess changes in penile tissue. Of these participants, 20 men, aged 27 to 72 years and a median age of 57, had complete data from both the questionnaires and the ultrasound scans, and their results were analyzed.
Results: The study's findings indicated that 70% of patients experienced improvements based on the International Prostate Symptom Score (IPSS). After treatment, there were statistically significant (P<0.05) enhancements in urinary incontinence symptoms, notably a 46.2% reduction in the frequency of nighttime urination and a 38.2% improvement in urinary control. According to the International Index of Erectile Function (IIEF) questionnaire, patients reported a 37.0% improvement in maintaining an erection until the completion of intercourse, a 24.2% increase in satisfaction with sexual intercourse attempts, a 10.7% increase in ejaculating frequency, and an 18.9% increase in the frequency of experiencing orgasms or climaxes. Furthermore, penile ultrasound scans showed an increase (N=11) in the number and density of tissue segments after treatment (69.0%), suggesting an enhancement in erectile function.
Conclusion: While initial results are promising, further research is imperative to fully understand and optimize treatment protocols, ensuring maximized benefits and contributing to the holistic well-being of patients. The continued investigation into HIFEM's applications and outcomes will be crucial in solidifying its role in treating these common male health issues.